Brookings Hutchins Center Fiscal Impact Measure Gauging Fiscal Policys Economic Influence US Jobless Claims Hold Near Historic Lows Underlining Labor Market Resilience Scotlands Green Datacentre Policy Faces Scrutiny Over AI Emissions Impact Analysis Shows Iran Refuses to Bow as Trump Rejects Peace Offer Extending Middle East Tensions Implications for Oil Markets Google Launches New AIIntegrated Smart Glasses Marking Return to Wearables After Glass Setback Flywire CEO Details Efficiency Improvements and AI Integration in Specialty Payment Markets MPC Q1 2026 Earnings Massive EPS Surprise of 1186 Drives Shares Higher CRK Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Natural Gas Environment STNE Q1 2026 Earnings EPS Misses Estimates Stock Slips as Growth Concerns Emerge Skye Bioscience Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Biotech Challenges KLIC Q1 2026 Earnings EPS Surges Past Estimates as Semiconductor Demand Holds Steady International Seaways Q1 2026 Earnings Strong EPS Beat Signals Robust Tanker Market Coastal Financial Corporation CCB Gains Ground Testing Key Resistance Levels Stran Company SWAG Surges 51 Approaching Key Resistance Levels Great Elm Capital Corp GECC Declines 189 Testing Critical Support Near 542 Rail Vision Shares Slide 56 as Support Levels Tested Regencell Bioscience RGC Edges Higher Approaches Key Resistance Level Jim Cramer Comments on What He Calls a Silly Aspect of Arm Holdings Stock Burberry Shares Surge on Report of Potential Moncler Takeover Bid Tourism Finance Corporation of India Gains Attention as Fund Linked to Rakesh Jhunjhunwala Acquires Stake Singapore Maintains 2026 GDP Forecast at 24 Amid Heightened Downside Risks from Iran Conflict Traders Bet on Fed Rate Hike by Mid2027 as Prediction Market Odds Rise Lidl Surpasses Morrisons to Claim FifthPlace Spot in UK Grocery Market Kyle Busch TwoTime NASCAR Champion Dies at 41 from Sepsis and Pneumonia DVLT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed Stock Surges 11 Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest